Literature DB >> 18413742

Matrix metalloproteinase-8 functions as a metastasis suppressor through modulation of tumor cell adhesion and invasion.

Ana Gutiérrez-Fernández1, Antonio Fueyo, Alicia R Folgueras, Cecilia Garabaya, Caroline J Pennington, Simon Pilgrim, Dylan R Edwards, Deborah L Holliday, J Louise Jones, Paul N Span, Fred C G J Sweep, Xose S Puente, Carlos López-Otín.   

Abstract

Collagenase-2 (matrix metalloproteinase-8, MMP-8) is an MMP mainly produced by neutrophils and associated with many inflammatory conditions. We have previously described that MMP-8 plays a protective role in cancer through its ability to regulate the inflammatory response induced by carcinogens. Moreover, it has been reported that experimental manipulation of the expression levels of this enzyme alters the metastatic behavior of human breast cancer cells. In this work, we have used mutant mice deficient in MMP-8 and syngenic melanoma and lung carcinoma tumor cells lines overexpressing this enzyme to further explore the putative antimetastatic potential of MMP-8. We report herein that MMP-8 prevents metastasis formation through the modulation of tumor cell adhesion and invasion. Thus, tumor cells overexpressing MMP-8 have an increased adhesion to extracellular matrix proteins, whereas their invasive ability through Matrigel is substantially reduced when compared with control cells. Analysis of MMP-8 in breast cancer patients revealed that the expression of this metalloproteinase by breast tumors correlates with a lower incidence of lymph node metastasis and confers good prognosis to these patients. On this basis, we propose that MMP-8 is a tumor protective factor, which also has the ability to reduce the metastatic potential of malignant cells in both mice and human.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18413742     DOI: 10.1158/0008-5472.CAN-07-5154

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  72 in total

Review 1.  Delving into somatic variation in sporadic melanoma.

Authors:  Vijay Walia; Euphemia W Mu; Jimmy C Lin; Yardena Samuels
Journal:  Pigment Cell Melanoma Res       Date:  2012-02-13       Impact factor: 4.693

2.  On how mammary gland reprogramming metalloproteinases couple form with function.

Authors:  Bonnie F Sloane
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-07-01       Impact factor: 10.005

Review 3.  Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?

Authors:  Santiago Rivera; Michel Khrestchatisky; Leszek Kaczmarek; Gary A Rosenberg; Diane M Jaworski
Journal:  J Neurosci       Date:  2010-11-17       Impact factor: 6.167

4.  What does matrix metalloproteinase-1 expression in patients with breast cancer really tell us?

Authors:  Ferdinando Mannello
Journal:  BMC Med       Date:  2011-08-11       Impact factor: 8.775

Review 5.  Pathomimetic cancer avatars for live-cell imaging of protease activity.

Authors:  Kyungmin Ji; Joshua Heyza; Dora Cavallo-Medved; Bonnie F Sloane
Journal:  Biochimie       Date:  2015-09-12       Impact factor: 4.079

Review 6.  Update in lung cancer 2008.

Authors:  Sarita Dubey; Charles A Powell
Journal:  Am J Respir Crit Care Med       Date:  2009-05-15       Impact factor: 21.405

7.  Mutational and functional analysis reveals ADAMTS18 metalloproteinase as a novel driver in melanoma.

Authors:  Xiaomu Wei; Todd D Prickett; Cristina G Viloria; Alfredo Molinolo; Jimmy C Lin; Isabel Cardenas-Navia; Pedro Cruz; Steven A Rosenberg; Michael A Davies; Jeffrey E Gershenwald; Carlos López-Otín; Yardena Samuels
Journal:  Mol Cancer Res       Date:  2010-10-13       Impact factor: 5.852

8.  alpha5beta1-integrin expression is essential for tumor progression in experimental lung cancer.

Authors:  Jesse Roman; Jeffrey D Ritzenthaler; Sussane Roser-Page; XiaoJuan Sun; ShouWei Han
Journal:  Am J Respir Cell Mol Biol       Date:  2010-01-15       Impact factor: 6.914

Review 9.  Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer.

Authors:  Evette S Radisky; Derek C Radisky
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-05-05       Impact factor: 2.673

10.  Functional interaction between acyl-CoA synthetase 4, lipooxygenases and cyclooxygenase-2 in the aggressive phenotype of breast cancer cells.

Authors:  Paula M Maloberti; Alejandra B Duarte; Ulises D Orlando; María E Pasqualini; Angela R Solano; Carlos López-Otín; Ernesto J Podestá
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.